• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将性别观点纳入主流的时机已到。

Time for gender mainstreaming in editorial policies.

出版信息

J Int AIDS Soc. 2011 Mar 8;14:11. doi: 10.1186/1758-2652-14-11.

DOI:10.1186/1758-2652-14-11
PMID:21385405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3059266/
Abstract

The HIV epidemic has been continuously growing among women, and in some parts of the world, HIV-infected women outnumber men. Women's greater vulnerability to HIV, both biologically and socially, influences their health risk and health outcome. This disparity between sexes has been established for other diseases, for example, autoimmune diseases, malignancies and cardiovascular diseases. Differences in drug effects and treatment outcomes have also been demonstrated. Despite proven sex and gender differences, women continue to be underrepresented in clinical trials, and the absence of gender analyses in published literature is striking. There is a growing advocacy for consideration of women in research, in particular in the HIV field, and gender mainstreaming of policies is increasingly called for. However, these efforts have not translated into improved reporting of sex-disaggregated data and provision of gender analysis in published literature; science editors, as well as publishers, lag behind in this effort.Instructions for authors issued by journals contain many guidelines for good standards of reporting, and a policy on sex-disaggregated data and gender analysis should not be amiss here. It is time for editors and publishers to demonstrate leadership in changing the paradigm in the world of scientific publication. We encourage authors, peer reviewers and fellow editors to lend their support by taking necessary measures to substantially improve reporting of gender analysis. Editors' associations could play an essential role in facilitating a transition to improved standard editorial policies.

摘要

艾滋病病毒在女性中的传播持续增加,在世界某些地区,感染艾滋病病毒的女性人数超过男性。女性在生理和社会方面更容易受到艾滋病病毒的影响,这影响了她们的健康风险和健康结果。这种性别差异在其他疾病中已经得到证实,例如自身免疫性疾病、恶性肿瘤和心血管疾病。药物作用和治疗结果的差异也已经得到证明。尽管已经证明存在性别差异,但女性在临床试验中的代表性仍然不足,而且发表的文献中缺乏性别分析的情况也很明显。越来越多的人倡导在研究中考虑到女性,特别是在艾滋病病毒领域,并且越来越要求将性别观点纳入政策主流。然而,这些努力并没有转化为改善按性别分类的数据报告和提供发表文献中的性别分析;科学编辑以及出版商在这方面落后了。期刊发布的作者指南包含许多关于良好报告标准的指导方针,因此这里不应缺少关于按性别分类的数据和性别分析的政策。编辑和出版商现在应该表现出领导能力,改变科学出版界的范例。我们鼓励作者、同行评审员和其他编辑通过采取必要措施来实质性地改进性别分析报告,给予支持。编辑协会可以在促进向改进的标准编辑政策过渡方面发挥重要作用。

相似文献

1
Time for gender mainstreaming in editorial policies.将性别观点纳入主流的时机已到。
J Int AIDS Soc. 2011 Mar 8;14:11. doi: 10.1186/1758-2652-14-11.
2
Prospective analyses of sex/gender-related publication decisions in general medical journals: editorial rejection of population-based women's reproductive physiology.前瞻性分析普通医学期刊中与性别相关的出版决策:编辑拒绝基于人群的女性生殖生理学研究。
BMJ Open. 2022 Feb 25;12(2):e057854. doi: 10.1136/bmjopen-2021-057854.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Statement on Publication Ethics for Editors and Publishers.编辑与出版商出版伦理声明。
J Korean Med Sci. 2016 Sep;31(9):1351-4. doi: 10.3346/jkms.2016.31.9.1351.
5
Association between women's authorship and women's editorship in infectious diseases journals: a cross-sectional study.女性作者与女性编辑在传染病学期刊中的关联:一项横断面研究。
Lancet Infect Dis. 2022 Oct;22(10):1455-1464. doi: 10.1016/S1473-3099(22)00367-X. Epub 2022 Jul 12.
6
"I don't see gender": Conceptualizing a gendered system of academic publishing.“我不认为性别有影响”:学术出版中性别化体系的概念化。
Soc Sci Med. 2019 Aug;235:112388. doi: 10.1016/j.socscimed.2019.112388. Epub 2019 Jun 27.
7
Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV/AIDS country reports.在应对艾滋病病毒方面是否存在性别差异?根据联合国大会关于艾滋病问题特别会议各国报告评估各国的艾滋病应对情况。
J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S111-8. doi: 10.1097/QAI.0b013e3181baeec2.
8
[Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use].[研究中的性别平等:SAGER 指南的基本原理及推荐用法]
Epidemiol Serv Saude. 2017 Jul-Sep;26(3):665-675. doi: 10.5123/S1679-49742017000300025.
9
Life and times of the impact factor: retrospective analysis of trends for seven medical journals (1994-2005) and their Editors' views.影响因子的发展历程:对七本医学期刊(1994 - 2005年)趋势的回顾性分析及其编辑观点
J R Soc Med. 2007 Mar;100(3):142-50. doi: 10.1177/014107680710000313.
10
Responsible research publication: international standards for editors.负责任的研究发表:编辑的国际标准
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35(3):35-41. doi: 10.1515/prilozi-2015-0006.

引用本文的文献

1
How do outcomes compare between women and men living with HIV in Australia? An observational study.澳大利亚感染艾滋病毒的女性和男性的治疗结果如何比较?一项观察性研究。
Sex Health. 2016 Apr;13(2):155-61. doi: 10.1071/SH15124.
2
Development and evaluation of 'briefing notes' as a novel knowledge translation tool to aid the implementation of sex/gender analysis in systematic reviews: a pilot study.“简报”作为一种新型知识转化工具以助力在系统评价中实施性别分析的开发与评估:一项试点研究
PLoS One. 2014 Nov 5;9(11):e110786. doi: 10.1371/journal.pone.0110786. eCollection 2014.
3
The challenges of including sex/gender analysis in systematic reviews: a qualitative survey.在系统评价中纳入性别分析的挑战:一项定性调查。
Syst Rev. 2014 Apr 10;3:33. doi: 10.1186/2046-4053-3-33.
4
Caring for women living with HIV: gaps in the evidence.关爱感染 HIV 的女性:证据中的空白。
J Int AIDS Soc. 2013 Oct 1;16(1):18509. doi: 10.7448/IAS.16.1.18509.
5
The impact of social context on self-management in women living with HIV.社会环境对 HIV 感染者女性自我管理的影响。
Soc Sci Med. 2013 Jun;87:147-54. doi: 10.1016/j.socscimed.2013.03.037. Epub 2013 Apr 3.
6
Gender-sensitive reporting in medical research.医学研究中的性别敏感报告。
J Int AIDS Soc. 2012 Mar 8;15(1):11. doi: 10.1186/1758-2652-15-11.

本文引用的文献

1
Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda.在乌干达,接受一线抗逆转录病毒治疗的成年患者 3 年前瞻性队列研究中,司他夫定毒性是导致女性治疗方案改变的主要原因。
J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):59-63. doi: 10.1097/QAI.0b013e3181f5bd03.
2
HIV/AIDS. Gender inequities must be addressed in HIV prevention.艾滋病毒/艾滋病。在艾滋病毒预防工作中必须解决性别不平等问题。
Science. 2010 Jul 9;329(5988):145-7. doi: 10.1126/science.1193794.
3
Putting gender on the agenda.将性别议题提上议程。
Nature. 2010 Jun 10;465(7299):665. doi: 10.1038/465665a.
4
Gender and sexuality: emerging perspectives from the heterosexual epidemic in South Africa and implications for HIV risk and prevention.性别与性取向:南非异性恋流行带来的新视角及其对艾滋病毒风险和预防的影响。
J Int AIDS Soc. 2010 Feb 9;13:6. doi: 10.1186/1758-2652-13-6.
5
Inclusion of women in clinical trials.将女性纳入临床试验。
BMC Med. 2009 Oct 9;7:56. doi: 10.1186/1741-7015-7-56.
6
Increasing participation of women in early phase clinical trials approved by the FDA.女性在获得美国食品药品监督管理局批准的早期临床试验中的参与度不断提高。
Womens Health Issues. 2009 Mar-Apr;19(2):89-93. doi: 10.1016/j.whi.2008.09.009.
7
HIV infection of the genital mucosa in women.女性生殖黏膜的HIV感染。
Curr HIV/AIDS Rep. 2009 Feb;6(1):20-8. doi: 10.1007/s11904-009-0004-1.
8
Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials.在临床试验中遵守关于性别与种族/族裔报告的联邦指南。
J Womens Health (Larchmt). 2006 Dec;15(10):1123-31. doi: 10.1089/jwh.2006.15.1123.
9
Sex differences in pharmacokinetics and toxicity of antiretroviral therapy.抗逆转录病毒疗法的药代动力学和毒性方面的性别差异。
Expert Opin Drug Metab Toxicol. 2006 Apr;2(2):273-83. doi: 10.1517/17425255.2.2.273.
10
Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism.HIV非核苷类逆转录酶抑制剂依非韦伦药代动力学的患者间变异性:性别、种族和CYP2B6基因多态性的影响
Br J Clin Pharmacol. 2006 Feb;61(2):148-54. doi: 10.1111/j.1365-2125.2005.02536.x.